Position in NVO
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$8,162,072
+$1,619,507 QoQ
Shares Held
170,256
-4.4% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.20%
of 13F equity value
Holder Rank
#165
of 1,350 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Carnegie Investment Counsel holds $159,457,484 across 11 Drug Manufacturers - General names. NVO ranks #6 (5.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
182,419 | $45,903,917 | |
| 2 | AMGN |
Amgen Inc
|
103,528 | $37,489,559 | |
| 3 | JNJ |
Johnson & Johnson
|
132,112 | $33,552,484 | |
| 4 | LLY |
ELI LILLY & Co
|
11,114 | $13,330,466 | |
| 5 | MRK |
Merck & Co., Inc.
|
71,923 | $9,242,105 | |
| 6 | NVO |
Novo Nordisk A S
This page
|
170,256 | $8,162,072 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
35,216 | $4,449,189 | |
| 8 | PFE |
Pfizer Inc
|
129,803 | $3,125,656 |
All Filings in NVO
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,162,072 | 170,256 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $6,542,565 | 178,029 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $12,468,093 | 245,049 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $15,141,500 | 272,869 | Shares | Sole | 2025-10-16 | |
| 2025-06-30 | $19,981,911 | 289,509 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $18,920,664 | 272,475 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $17,078,840 | 198,545 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $25,420,730 | 213,494 | Shares | Sole | 2024-10-10 | |
| 2024-06-30 | $30,627,150 | 214,566 | Shares | Sole | 2024-07-22 | |
| 2024-03-31 | $27,259,833 | 212,304 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $21,347,114 | 206,352 | Shares | Sole | 2024-01-30 | |
| 2023-09-30 | $18,216,373 | 200,312 | Shares | Sole | 2023-10-11 | |
| 2023-06-30 | $14,592,372 | 90,171 | Shares | Sole | 2023-08-04 | |
| 2023-03-31 | $14,165,528 | 89,013 | Shares | Sole | 2023-04-20 | |
| 2022-12-31 | $11,273,822 | 83,300 | Shares | Sole | 2023-01-24 | |
| 2022-09-30 | $6,041,961 | 60,644 | Shares | Sole | 2022-10-14 | |
| 2022-06-30 | $6,846,482 | 61,442 | Shares | Sole | 2022-08-02 | |
| 2022-03-31 | $7,026,799 | 63,276 | Shares | Sole | 2022-04-11 | |
| 2021-12-31 | $7,320,208 | 65,359 | Shares | Sole | 2022-01-21 | |
| 2021-09-30 | $6,386,489 | 66,519 | Shares | Sole | 2021-10-08 | |
| 2021-06-30 | $5,538,286 | 66,113 | Shares | Sole | 2021-07-16 | |
| 2021-03-31 | $4,532,174 | 67,223 | Shares | Sole | 2021-04-12 | |
| 2020-12-31 | $4,664,792 | 66,783 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $4,679,373 | 67,397 | Shares | Sole | 2020-10-13 | |
| 2020-06-30 | $4,460,628 | 68,122 | Shares | Sole | 2020-07-09 | |
| 2020-03-31 | $4,137,184 | 68,724 | Shares | Sole | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||